Editorial Expression of Concern: The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors
Year: 2026
Type: editorial
Abstract: Editorial Expression of Concern to: Cell Death & Disease https://doi.org/10.1038/cddis.2014.396 , published online 09 October 2014
Source: Cell Death and Disease
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,990
OpenAlex ID: W7214366175
